U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H32Cl2N2O5S
Molecular Weight 591.546
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of LUSUTROMBOPAG

SMILES

CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C2=CSC(NC(=O)C3=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C3)=N2

InChI

InChIKey=NOZIJMHMKORZBA-KJCUYJGMSA-N
InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C29H32Cl2N2O5S
Molecular Weight 591.546
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:04:29 UTC 2023
Edited
by admin
on Sat Dec 16 18:04:29 UTC 2023
Record UNII
6LL5JFU42F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LUSUTROMBOPAG
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
LUSUTROMBOPAG [USAN]
Common Name English
(2E)-3-{2,6-Dichloro-4-[(4-{3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl}-1,3-thiazol-2-yl)carbamoyl]phenyl}-2-methylprop-2-enoic acid
Systematic Name English
LUSUTROMBOPAG [ORANGE BOOK]
Common Name English
2-PROPENOIC ACID, 3-(2,6-DICHLORO-4-(((4-(3-((1S)-1-(HEXYLOXY)ETHYL)-2-METHOXYPHENYL)-2-THIAZOLYL)AMINO)CARBONYL)PHENYL)-2-METHYL-, (2E)-
Common Name English
lusutrombopag [INN]
Common Name English
MULPLETA
Brand Name English
RSC888711
Code English
S-888711
Code English
LUSUTROMBOPAG [JAN]
Common Name English
Lusutrombopag [WHO-DD]
Common Name English
LUSUTROMBOPAG [MI]
Common Name English
Classification Tree Code System Code
WHO-ATC B02BX07
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
Code System Code Type Description
DRUG CENTRAL
5059
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
ChEMBL
CHEMBL2107831
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
JAPANESE REVIEW
MULPLETA
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY APPROVED SEPTEMBER 2015
EVMPD
SUB183903
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
USAN
ZZ-110
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
PUBCHEM
49843517
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
DRUG BANK
DB13125
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
RXCUI
2054984
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
WIKIPEDIA
Lusutrombopag
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
EPA CompTox
DTXSID701027951
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
DAILYMED
6LL5JFU42F
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
CAS
1110766-97-6
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
NCI_THESAURUS
C166948
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
SMS_ID
100000170082
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
MERCK INDEX
m12103
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
FDA UNII
6LL5JFU42F
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
INN
9410
Created by admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
TARGET -> INHIBITOR
TARGET -> INHIBITOR
MINOR
TARGET -> INHIBITOR
TARGET -> INHIBITOR
MINOR
TARGET -> INHIBITOR
MINOR
TARGET -> INHIBITOR
MINOR
TARGET -> SUBSTRATE
BINDER->LIGAND
TARGET -> SUBSTRATE
TARGET -> INHIBITOR
MINOR
TARGET -> INHIBITOR
MINOR
TARGET -> AGONIST
IC50
TARGET -> INHIBITOR
MINOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC ORAL ADMINISTRATION

Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC DOSE